Non-regulatory news

Observe Medical – First orders to the Irish Hospital Market

Oslo, February 13, 2024 – Observe Medical ("the Company" or "Observe Medical") has received first orders for delivery of UnoMeter™ 500 products from our distributor in Ireland, Armstrong Medical. We are set to dispatch 2,800 units of the UnoMeter™ 500 this week, with an additional 2,500 units scheduled for shipment by the end of February. The…

Read more

Observe Medical expands into the Asian market

Oslo, January 18, 2024 – Observe Medical ("the Company" or "Observe Medical") announces the expansion of its UnoMeter portfolio into the Asian market, with UnoMeter 500 orders received from Thailand and Vietnam. This expansion not only diversifies our market presence but also reinforces Observe Medical’s commitment to global growth and establishing a strong foothold in regions…

Read more

Observe Medical – First order to Portugal

Oslo, January 4, 2024 – Observe Medical ("the Company" or "Observe Medical") has received first order from our distributor in Portugal, Aviquímica, for delivery of UnoMeter 500 products. The UnoMeter portfolio is experiencing rapid expansion, having recently secured orders from Portugal, bringing the total count to 18 countries. The favorable clinical evaluations contribute positively to the…

Read more

Observe Medical – Milestone production capacity reached for UnoMeter 500

Oslo, December 12, 2023 – Observe Medical ("the Company" or "Observe Medical") is thrilled to share that the production capacity of our flagship product, UnoMeter 500, has now reached a level on par with the historical benchmarks set by Convatec. In a remarkably short span of time, we have achieved a production capacity equivalent to Convatec's…

Read more

Observe Medical signs LOI with German distributor

Oslo, December 8, 2023 – Observe Medical (the “Company" or "Observe Medical") is excited to announce a significant milestone in our global expansion strategy with the signing of a Letter of Intent (LOI) for distribution of the UnoMeter portfolio in the German market. The agreement marks our entry into the German market and has been formalized…

Read more

Observe Medical – First order to Croatia

Oslo, December 6, 2023 – Observe Medical (the “Company" or "Observe Medical") has received first order for delivery of UnoMeter 500 and Abdo Pressure products from our distributor in Croatia, Stoma Medical.   The UnoMeter portfolio is experiencing rapid expansion, having recently secured orders from Croatia, bringing the total count to 17 countries. The favorable clinical…

Read more

Observe Medical – First order to Slovakia

Oslo, November 29, 2023 – Observe Medical (the "Company" or "Observe Medical") has received first order for delivery of UnoMeter Abdo Pressure products from our distributor in Slovakia, Unomed.   The UnoMeter portfolio is rapidly extending its reach and with the addition of Slovakia, we have now secured orders from a total of 16 countries. With…

Read more

Observe Medical ASA – Invitation to a Company presentation 4 December 2023

Oslo, 29 November 2023 – Observe Medical ASA (OSE: OBSRV) (the “Company" or "Observe Medical") will host a Company presentation Monday 4 December 2023, at 13:00 CET. The presentation will take place virtually on Microsoft Teams Live Event, and is hosted by SpareBank 1 Markets. Please use the following link to join www.bit.ly/OBSRV23 (https://eur03.safelinks.protection.outlook.com/?url=httpwww.bit.lyOBSRV23&data=0501perarne.nygardobservemedical.comffccd96ce09a4a65ebb808dbefeb08dc139dbc03ecf246efb467a338c990a8d600638367564980273081UnknownTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn03000&sdata=9CZ7I1MkfbxrBhwzeMxEcPdP1AGrmZQwHXmugcC33U&reserved=0). The presentation…

Read more

Observe Medical – New order and distribution agreement with ReplantMed

Oslo, November 28, 2023 – Observe Medical ("the Company" or "Observe Medical") announces a new order and distribution agreement with ReplantMed, our Hungarian distributor. The UnoMeter portfolio is continuously expanding footprint with total orders from 15 countries, demonstrating its widespread market and global demand. Positive clinical evaluations further strengthen the quality and performance of the UnoMeter…

Read more

Observe Medical – UnoMeter orders continue to come in from both new and existing customers and the geographical footprint is expanding

Oslo, November 10, 2023 – Observe Medical ("the Company" or "Observe Medical") has received follow-up orders from several distributors including the Spanish distributor, BM2 Health, for delivery of UnoMeter Abdo Pressure products, with most recent follow-up orders having a value of approx. NOK 1,3 million. The total value of orders for the UnoMeter product range has…

Read more

Observe Medical – First shipment of UnoMeter[TM] 500 products

Oslo, October 26, 2023 – Observe Medical ("the Company" or "Observe Medical") today announces the shipment of the first UnoMeter[TM] 500 products to distributors in Poland and Spain. Containers carrying over 96,000 UnoMeterTM 500 products are now loaded at our OEM factory and set to ship on October 30th, which build upon the previous stock announcement…

Read more

Observe Medical delivers 20 new ultrasound probes to Fresenius Medical Care

Oslo, October 17, 2023 – Observe Medical (OSE: OBSRV) Observe Medical ("the Company" or "Observe Medical") today announces that it has delivered 20 Biim ultrasound probes to Fresenius Medical Care in the US. As part of the partnership agreement with Fresenius Medical Care, Observe Medical has delivered 20 Biim ultrasound probes to Fresenius Medical Care,…

Read more

Link to the recording of the Company presentation held 6 June, 2023

Link to the recording of the live event: https://attendee.gotowebinar.com/recording/1358614173515479296 For further information, please contact:   Rune Nystad, CEO Observe Medical Mobile: +47 916 24 683 E-mail: rune.nystad@observemedical.com Per Arne Nygård, CFO of Observe Medical Mobile: +47 411 04 345 E-mail: perarne.nygard@observemedical.com About Observe Medical   Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech…

Read more

Observe Medical ASA: Invitation to a Company presentation 6 June, 2023

Oslo, 5 June 2023 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) will host a Company presentation Tuesday, 6 June 2023, at 14:00 CEST. The presentation will take place virtually on Microsoft Teams Live Event, and is hosted by SpareBank 1 Markets. Please register to corporateaccess@sb1markets.no to receive a link to join.…

Read more

Update on acquisition of Ferrari L. and Shareholder Letter

Oslo, 20 April 2023 – Observe Medical ASA ("the Company" or "Observe Medical") today announces it has informed Ferrari L., an Italian manufacturer of medical equipment, that the Company has decided to discontinue the process of acquiring Ferrari L. The contemplated acquisition was originally announced in a press release on 14 December 2022. This decision…

Read more

Observe Medical ASA – Company presentation

Oslo, 6 March 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) has prepared an updated company presentation which can be found attached. The presentation is also available on www.observemedical.com For further information, please contact:   Rune Nystad, CEO Observe Medical Mobile: +47 916 24 683 E-mail: rune.nystad@observemedical.com Per Arne Nygård, CFO of Observe Medical Mobile:…

Read more

Observe Medical ASA: Status update on Letters of Intent

Oslo, 3 March 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) today provides an update on the initial letters of intent (LOIs) that have been sent to distributors of the Unometer portfolio. As previously announced, Observe Medical is in the process of confirming orders with distributors of Unometer Safeti Plus, AbdoPressure and Sippi.…

Read more

Shareholder letter

Oslo, March 2, 2023 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter. The letter to our shareholders is enclosed to this release. For further information, please…

Read more

Observe Medical ASA: Invitation to fourth quarter 2022 presentation

Oslo, 10 February 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) will release its fourth quarter 2022 results on Friday, 17 February 2023. The presentation will be made available on NewsWeb and the Company's website at 07:00 CET on the same day. Rune Nystad, CEO, and Per Arne Nygård, CFO, will host a presentation…

Read more

Shareholder Letter

Oslo, January 10, 2023 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter. The letter to our shareholders is enclosed to this release. For further information, please…

Read more

Observe Medical ASA announces the appointment of Chief Commerical Officer

Oslo, 10 January 2023 – Observe Medical ASA ("the Company" or "Observe Medical") announces it has appointed Jørgen Mann as the Company’s Chief Commercial Officer. With nearly 20 years of experience in sales and senior management roles from global medtech companies in Europe, he brings highly relevant experience to Observe Medical, as the company strengthens…

Read more

Observe Medical to present at the DNB Nordic Healthcare Conference

Oslo, December 15, 2022 – Observe Medical ASA ("Observe Medical" or "the Company") today announce that Rune Nystad, CEO of Observe Medical, will present at the 13th annual DNB Nordic Healthcare Conference in Oslo, Norway, today on Thursday, December 15, 2022, at 15.35 CET. The presentation is attached to this announcement. For further information, please…

Read more

Observe Medical ASA –  Invitation to third quarter 2022 presentation

Oslo, October 26, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical"or the "Company"), will release its third quarter 2022 results on Thursday, 3 November 2022. The presentation will be made available on NewsWeb and the Company’s website at 07:00 CET on the same day. Rune Nystad, CEO, and Per Arne Nygård, CFO, will host…

Read more

Shareholder Letter

Oslo, October 25, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter. The letter to our shareholders is enclosed to this release. For…

Read more

Observe Medical ASA announces appointment of Chief Technology Officer

Oslo, 9 September 2022 – Observe Medical ASA (“the Company” or “Observe Medical”), is pleased to announce the appointment of Carsten Trygve Bøgh as Chief Technology Officer (CTO), effective 2 October 2022. Mr. Bøgh has a long-standing medtech career, having led several innovative product launches, delivered impactful results, and reached value-inflection milestones for companies. “We…

Read more

Shareholder Letter

Oslo, September 5, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter (in Norwegian). The letter to our shareholders is enclosed to this…

Read more

Observe Medical receives MDR certification under the new European Medical Device Regulation

Oslo, April 1, 2022 – Observe Medical ASA ("the Company" or "Observe Medical") today announces that the Sippi® Disposable Unit has received Medical Device Regulation Certification, ensuring continued market access for the unit in Europe after 2024.  Rune Nystad, CEO of Observe Medical, commented: "The MDR Certification confirms that the Sippi® Disposable Unit is compliant with…

Read more

Observe Medical ASA: Sippi® clinical rollout accelerates, and clinical evaluations driving the health economic value of Sippi®

Oslo, October 22, 2021 – Observe Medical ASA (OSE: OBSRV) continues its rollout of Sippi®, and reports clinical implementation at several sites in Europe – including use outside intensive care units, and clinical evaluations driving the health economic value of Sippi®  “We are excited to see Sippi® implementation gaining momentum as society and hospitals now…

Read more

Observe Medical ASA: Major Italian hospital implements Sippi® wirelessly connected in the Intensive Care department

Oslo, September 27th, 2021 – Observe Medical ASA (OSE: OBSRV) continues its rollout of Sippi®, and today announces that a major regional hospital in Italy has decided to implement Sippi® in the intensive care unit (ICU), with wireless connection to the hospital’s patient data management system. “The decision by a major Italian hospital to implement…

Read more

Observe Medical – Nya Karolinska Sjukhuset initiates new studies to broaden the clinical scope of use for Sippi®

Oslo May 07, 2021 – Observe Medical ASA (OSE: OBSRV), announces that Nya Karolinska Sjukhuset, Sweden, prepares new studies to broaden the clinical scope of use for Sippi® automated, digital urine measurement system, building further on the results from the recent dissertation by Dr Martin Slettengren. Following the recent dissertation by Dr. Martin Slettengren, ”Evaluation…

Read more

Observe Medical further expands and strengthens the global patent protection for Sippi® proprietary technology

Oslo May 6, 2021 – Observe Medical ASA (OSE: OBSRV), announces that Sippi® automated and digital urine meter recently received new patent approvals in India, China and Brazil, further expanding and strengthening the global patent protection for Sippi® proprietary technology. “We are pleased to announce that Sippi® since end March this year, has received three…

Read more

Observe Medical: Delivering blood & fluid warmer systems to three Nordic hospitals

Oslo 8 March 2021 – Observe Medical ASA (OSE: OBSERV), today announces an order to deliver a newly introduced blood & fluid warmer system, including disposable supplies, to two university hospitals and one regional hospital in Nordic market.  “This is a breakthrough order for an innovative and newly introduced blood & fluid warmer system and…

Read more

Observe Medical – Nya Karolinska Sjukhuset in Sweden resumes the implementation of Sippi® in clinical use at Cardiothoracic ICU unit

Oslo February 22, 2021 – Observe Medical ASA (OSE: OBSERV), announces that Nya Karolinska Sjukhuset in Stockholm, Sweden resumes the implementation of Sippi® in clinical use at the Cardiothoracic ICU unit following a pause during 2020, due to Covid-19    As a result of the recent improvements of the Covid-19 situation at the hospital, the…

Read more

Observe Medical ASA – Strengthened presence in Norway through collaborations with Yallow Life Science AS and Norway Health Tech

Oslo February 4, 2021 – Observe Medical ASA (OSE: OBSERV), announces strengthened presence in Norway through a partnership agreement with the Norwegian medtech agency Yallow Life Science AS and an enhanced collaboration with Norway Health Tech.   Observe Medical, with headquarters in Oslo, Norway, is launching Sippi® automated digital urine meter in selected markets in Europe.…

Read more

Observe Medical ASA – Doctoral dissertation further demonstrates clinical benefits of Sippi®

Observe Medical ASA, January 15, 2021 – A doctoral (PhD) dissertation at Karolinska Institute, Stockholm, Sweden, demonstrates multiple clinical benefits of the Sippi® automated digital urine meter, and the potential paradigm shift in clinical practice of urine measurement. The PhD thesis ‘Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation…

Read more

Observe Medical ASA – Enhanced Nordic sales team in full operations, driving Sippi® clinical use in the Nordics, following the recent acquisition of Sylak AB

Observe Medical ASA, December 21, 2020: Following the acquisition by Observe Medical of Sylak AB on October 30, the team and product portfolio are now successfully integrated into Observe Medical and in full operations, with focus on the Swedish market. Observe Medical is currently launching Sippi® automated digital urine meter in selected markets in Europe,…

Read more

Observe Medical: Scientific article provides evidence of Sippi® technology reducing microbial biofilm formation – a risk factor for patient infection

A recently published article demonstrates that the patented Sippcoat® technology, an integrated part of Sippi® system, from Observe Medical, significantly reduces microbial biofilm formation in medical devices, suggesting a new strategy for reducing hospital-acquired infections. The article “Making medical devices safer: impact of plastic and silicone oil on microbial biofilm formation” was recently published in…

Read more

Observe Medical signs updated distribution agreement for Sippi® in Italy

Oslo 7 August 2020 – Observe Medical ASA (OSE: OBSERV), today announces it has entered into an updated distribution agreement and strengthened partnership with SIM Italia S.r.l. for the launch of Sippi® in the Italian market. “We are pleased to announce our strengthened partnership with SIM Italia and the signing of an updated distribution agreement…

Read more

Observe Medical ASA: Business update in light of COVID-19

Oslo, 19 March 2020 – Observe Medical ASA (OSE: OBSERV) today provides a business update in light of COVID-19. The company reports continued high activity level in operations, and several initiatives in the launch and roll-out of Sippi®. “The evolving COVID-19 situation has serious impact on all aspects of the global society, specifically the healthcare…

Read more